Relmada Therapeutics is advancing NDV-01, a novel intravesical therapy for NMIBC, into phase 3 clinical trials, with Max Kates, M.D., joining their advisory board. NDV-01 combines gemcitabine and ...
Azitra, Inc. (NYSE:AZTR) reported third quarter 2025 results in a November 12th press release and provided a business update. Since our previous quarterly update in August, Azitra has announced that ...
Photo Credit: IPhone apps for OYO, Airbnb Trivago, Booking.com, Expedia, Agoda, Hotels.com and Hostelworld. Adobe Stock / Koshiro K On the competitive disadvantage front, Dan Wasiolek, senior equity ...
You have /5 articles left. Sign up for a free account or log in. Purdue University is ending its GEAR UP program after the Trump administration canceled a $34.9 ...
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 19, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of ...
The Trump administration has not yet ended a federal program that sets goals for minority participation in federally funded contracts. But MDOT Director Bradley Wieferich told the State Transportation ...
Chelsea Cirruzzo is a Washington correspondent at STAT, where she covers HHS. You can reach Chelsea on Signal at chelseacirruzzo.42. WASHINGTON — Health secretary Robert F. Kennedy Jr. has assembled a ...
San Francisco is launching a new program backed by Democratic California Gov. Gavin Newsom that will issue speeding tickets based on income. The Speed Safety System Pilot Program was signed by Newsom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback